Evaluating True PCR-negative Rate of Frontline Dasatinib in Early Chronic Phase CML for Therapeutic Harmonization
Clinical trial NCT02975115 · UNKNOWN
Trial details
- NCT number
- NCT02975115
- Sponsor
- Seoul St. Mary's Hospital
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2013-11-01
- Primary completion
- 2016-11-01
- Enrollment
- 102
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.